Okay, so picture this. You’re deep in an Ozempic subreddit at 11pm, and thread after thread is full of people describing things your doctor never mentioned. Fatigue that hits like a wall. Hair showing up in your shower drain in alarming amounts. Feeling weirdly cold all the time. Temperature swings out of nowhere. And you’re thinking… wait, is this just me?

It’s not just you. And science is starting to catch up.

Just a quick note: I’m not a doctor, and this blog is meant to share my personal experiences and helpful resources. Always consult your healthcare provider before making any changes to your treatment plan.

_{Disclosure: This post contains affiliate links. As an Amazon Associate, I earn from qualifying purchases at no extra cost to you. I only recommend products I truly use and love.}

The Penn AI Study Everyone Is Talking About

Researchers at the University of Pennsylvania did something kind of brilliant. They used AI to analyze over 400,000 Reddit posts from nearly 70,000 people who reported taking GLP-1 medications (specifically semaglutide and tirzepatide) over more than five years.

The findings were published in the journal Nature Health in April 2026, and the results were kind of eye-opening. The study flagged two main categories of symptoms that keep coming up online but aren’t well-documented in clinical trial data: reproductive symptoms (like irregular menstrual cycles) and temperature-related complaints (chills, feeling cold, hot flashes).

Fatigue also ranked as the second most commonly reported symptom overall but barely met reporting thresholds in existing clinical trials. That gap between what patients are experiencing and what gets officially documented? That’s exactly what motivated this whole line of research.

Now, the researchers are very clear: this does not prove that GLP-1s are causing these symptoms. What it does is surface signals worth investigating. And that matters a lot.

Why Clinical Trials Miss Stuff (It’s Not a Conspiracy, Just… Science Limitations)

Before we spiral, let’s talk about why this happens. It’s not shady. It’s just how clinical research is structured, and it has some real gaps.

Short follow-up windows

Most GLP-1 trials run 68 to 104 weeks, which sounds like plenty of time. But trials are built around a primary endpoint, a specific point where the main results get measured and reported. Side effects that build slowly or show up after that endpoint gets analyzed can end up underreported, even in a trial that technically ran long enough to see them.

Who gets included in trials

Clinical trial participants are often healthier than the average person who eventually takes a medication. They tend to exclude people with certain pre-existing conditions, which means rare interactions or vulnerabilities can slip through undetected until millions of real-world people are using the drug.

Statistical power for rare events

If a side effect hits a small percentage of users, like the 2.5% of Wegovy patients in trials who experienced hair loss, it can technically be in the data but still get buried next to GI symptoms affecting half of all patients. If something is even rarer, say 1 in 5,000 people, you’d need a massive trial to detect it reliably at all. Most trials aren’t that size.

Reddit, for all its chaos, captures something trials can’t: huge numbers of real people, over long periods, talking freely about what they’re actually experiencing.

The Side Effects Getting the Most Reddit Attention (With Real Context)

Let’s break down the big ones. Fair warning: I’m going to give you actual context here, not just a doom scroll of scary bullet points.

1. Fatigue (The One Nobody Warned You About)

Fatigue was the second most reported symptom in the Penn study but barely registered in clinical trial data. Users describe it as more than just feeling tired. We’re talking “can’t get off the couch” tired, especially in the early weeks or after dose increases.

What might be driving it? Theories include reduced caloric intake affecting energy levels, your body adjusting to appetite suppression, and potential interactions with how GLP-1 drugs affect the hypothalamus (the part of the brain that regulates energy and hormones). Nothing is confirmed, but it’s worth logging and flagging with your provider.

2. Hair Loss (Yes, It’s Real, and Here’s What Actually Causes It)

GLP-1 hair loss is one of the most searched hidden GLP-1 side effects across patient communities right now. This one comes up constantly on r/Ozempic and r/WegovyWeightLoss. People describing clumps in the shower, thinning at the temples, brushes full of hair. Alarming. And often blindsiding, because it tends to hit around months 3 to 6, long after you’ve adjusted to the medication.

The most well-supported explanation is something called telogen effluvium. Here’s the short version: when your body experiences a significant physical stressor (like rapid weight loss), it can push hair follicles out of the growth phase and into the resting phase all at once. A few months later, those hairs shed simultaneously.

Novo Nordisk has actually confirmed hair loss as an identified risk with semaglutide. In Wegovy clinical trials, it was reported in about 2.5% of patients, compared to 1% on placebo. It also showed up more in people who lost over 20% of their body weight.

The good news? This type of hair loss is generally temporary. Making sure you’re getting enough protein, iron, zinc, and biotin matters a lot here. A quality biotin and hair support supplement is something a lot of people in the GLP-1 community swear by during this phase.

Hair. Not an emergency. But worth bringing up with your doctor.

3. Temperature Sensitivity and Feeling Cold

This was one of the Penn study’s most notable underreported findings. People describing chills, feeling cold when others aren’t, hot flashes, and temperature swings that seem completely random.

One theory is that GLP-1 drugs act on the hypothalamus, which helps regulate body temperature in addition to hunger and hormones. So it’s plausible the medication is affecting thermoregulation. Again, not confirmed, but not random either.

This one tends to ease up over time for many people. Layering up and staying hydrated can help short-term.

4. Mood and Mental Health Changes

The Penn study found that about 13% of users who reported side effects mentioned something in the psychiatric category, including anxiety, insomnia, or depression.

This one deserves nuance. The FDA looked closely at reports of suicidal thoughts in GLP-1 users and in March 2026 actually concluded there was no evidence of a causal link, ultimately removing the suicidal ideation warning from GLP-1 labels after a comprehensive review. That’s important context.

That said, mood changes are real for some people. GLP-1 drugs affect the brain, including reward pathways and appetite signals. Losing weight can also be emotionally complex, and your relationship with food is changing at a deep level. If you’re feeling off mentally, that’s worth talking about with your provider, not ignoring.

5. Vision Changes (The One to Take Seriously)

This is probably the most important one on this list, so heads up. There is growing research linking semaglutide use to a rare eye condition called NAION (non-arteritic anterior ischemic optic neuropathy). It’s basically a reduction in blood flow to the optic nerve, and for most people it causes permanent vision loss in the affected area.

A 2024 study published in JAMA Ophthalmology found that semaglutide users had a higher risk of NAION compared to people on other medications. The European Medicines Agency launched a review of the issue in early 2025 and listed NAION as a “very rare” side effect of semaglutide. The American Optometric Association has also issued guidance to eye doctors about monitoring GLP-1 patients.

To be very clear: this is rare. But the consequences are serious and often irreversible. If you notice any sudden changes in your vision, blurriness, or loss of part of your visual field, contact your eye doctor immediately. Do not wait and see.

What Reddit Gets Right (and Where to Be Skeptical)

Okay, real talk. Reddit is incredible for surfacing lived experience at scale. The Penn researchers literally said that’s the point. When tens of thousands of people describe the same thing independently, that’s a signal worth paying attention to.

But Reddit is also a place where fear spreads fast, where one bad experience gets 500 upvotes and ten normal experiences get none. The Penn researchers themselves cautioned that their findings are not proof of causation. Social media skews toward negative experiences (who posts “everything is fine”?), and people posting may not represent all GLP-1 users.

Use it as information, not as your diagnosis.

What to Actually Do With This Information

Here’s the practical part:

• Log what you’re experiencing. Write down symptoms, when they started, and any patterns. A simple notebook or symptom tracker works great for this.
• Talk to your prescriber. “I read a Reddit thread” is fine. Bring specifics. A good provider wants to know what you’re experiencing, even if it’s not in the official leaflet.
• Report to the FDA. For real. You can submit a report at fda.gov/medwatch, or call 1-800-332-1088. FAERS data is how regulators detect real-world signals. Your experience could help someone else down the line.
• Know when to stop. Sudden vision changes warrant stopping the medication and calling your doctor that day. Severe abdominal pain, signs of pancreatitis, or anything that feels serious needs immediate attention.
• Don’t self-diagnose from Reddit. Use it to inform the conversation with your doctor, not replace it.

You’re Not Making It Up

If you’ve been experiencing something on this medication that your doctor brushed off or that wasn’t in any of the clinical literature, this research is part of why that happens. Trials miss things. Real-world data takes time to catch up. Reddit, for all its chaos, is filling a genuine gap.

You’re not dramatic. You’re not imagining it. You’re one of millions of real people living inside a drug’s actual story, not just its clinical trial summary.

Keep showing up for yourself, keep asking questions, and know that the research is literally catching up to your experience. You’ve got this. 💚